Cetera Advisors’s iBio IBIO Stock Holding History

Cetera Advisors’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-21	Closed	-$21K	–	1050
2020 Q3	$21K	Buy	+21	New	+$30.4K	﹤0.01%	946

Other funds holding IBIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Cetera Advisors's IBIO Position: Q4 2020 in Review

Cetera Advisors sold out of iBio (IBIO) in Q4 2020, closing a stake of 21 shares — an estimated $21K sold.

Cetera Advisors first reported a position in IBIO in Q3 2020 and held it in 1 quarter. The position peaked at $21K in Q3 2020. 89 funds tracked by Wall St. Rank hold IBIO as of Q4 2020.

Cetera Advisors reported no remaining iBio position as of Q4 2020 after selling out during the quarter.
Cetera Advisors sold 21 iBio shares in Q4 2020, an estimated $21K.
Cetera Advisors first reported a position in iBio in Q3 2020 and held it in 1 quarter.
Cetera Advisors's iBio position peaked at $21K in Q3 2020.
89 funds tracked by Wall St. Rank held iBio as of Q4 2020.

Based on Cetera Advisors's 13F filing for Q4 2020, filed 17 Feb 2021.